Indian Journal of Medical Biochemistry

Register      Login

VOLUME 21 , ISSUE 2 ( July-December, 2017 ) > List of Articles


Study of Insulin Resistance in Women with Preeclampsia

Amit D Sonagra, Zahoorunissa Deba, Asmabi Makandar, Shivaleela M Biradar

Citation Information : Sonagra AD, Deba Z, Makandar A, Biradar SM. Study of Insulin Resistance in Women with Preeclampsia. Indian J Med Biochem 2017; 21 (2):127-130.

DOI: 10.5005/jp-journals-10054-0035

License: NA

Published Online: 01-12-2017

Copyright Statement:  NA



The root cause of preeclampsia is placental ischemia due to impaired trophoblastic invasion in the uterine spiral arterioles. Ischemic placenta liberates various inflammatory mediators that cause widespread endothelial dysfunction leading to insulin resistance (IR). Increased IR in pregnant females can further lead to high occurrence of maternal and fetal complications.


To compare and evaluate the role of measuring IR among women with preeclampsia and normal pregnancy.

Materials and methods

A total of 35 women with preeclampsia and 35 women with normal pregnancy were included in the study as cases and controls, respectively. Fasting plasma glucose (FPG) and fasting plasma insulin (FI) were measured and IR indices, such as FPG to FI ratio (FGIR), quantitative insulin sensitivity check index (QUICKI), and log FI were calculated. Unpaired Student's t-test was used for comparison. Statistical analysis was done using Statistical Package for the Social Sciences (SPSS) version 17.0.


The mean FI and log FI were significantly higher while QUICKI and FGIR were significantly lower in cases when compared with controls (p < 0.001).


As disease advances, IR increases. There is increased risk of maternal and fetal complications in presence of increased IR. Screening of all hypertensive pregnancies for IR and timely intervention may help to improve outcome.

How to cite this article

Sonagra AD, Deba Z, Makandar A, Biradar SM. Study of Insulin Resistance in Women with Preeclampsia. Indian J Med Biochem 2017;21(2):127-130.

  1. A historical overview of preeclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs 2010 Sep;39(5):510-518.
  2. PIH: the challenge. In: Shah M, editor. Hypertensive disorders in pregnancy. New Delhi: Jaypee Brothers; 2007. pp. 1-9.
  3. Hypertension in pregnancy. In: Desai P, Malhotra N, Shah D, editors. Principles and practice of obstetrics and gynaecology for post-graduates. 3rd ed. New Delhi: Jaypee Brothers; 2008. p. 100-107.
  4. ; Lenevo, KJ.; Bloom, SL., et al. Pregnancy hypertension. In: Cunningham FG, Lenevo KJ, Bloom SL, et al., editors. Williams obstetrics. 23rd ed. New York (NY): The McGraw-Hill Companies; 2010. pp. 706-728.
  5. Structural changes of placenta in preeclamptic patients: light and electron microscopic study. Turk J Med Sci 2008 Jun;38(3):219-225.
  6. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008 Feb;294(2):H541-H550.
  7. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011 Jun;123(24):2856-2869.
  8. Obesity, insulin resistance, and pregnancy outcome. Reproduction 2010 Sep;140(3):365-371.
  9. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991 Mar;14(3):173-194.
  10. Carbohydrates. In: Brutis C, Ashwood E, Bruns D, editors. Teitz textbook of clinical chemistry and mole-cular diagnostics. 4th ed. New Delhi: Elsevier; 2006. pp. 868-875.
  11. Principles of immunochemical techniques. In: Brutis C, Ashwood E, Bruns D, editors. Teitz textbook of clinical chemistry and molecular diagnostics. 4th ed. New Delhi: Elsevier; 2006. pp. 219-244.
  12. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001 Nov;86(11):5457-5464.
  13. Maternal preeclampsia and neonatal outcomes. J Pregnancy 2011 Feb;2011:214365.
  14. Relationship among age, insulin resistance, and blood pressure. J Am Soc Hypertens 2017 Jun;11(6):359-365.
  15. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes 2010 Jan;59(1):89-97.
  16. Normal pregnancy-a state of insulin resistance. J Clin Diagn Res 2014 Nov;8(11):CC01-CC03.
  17. Hyperinsulinemia increases the risk of gestational hypertension. Int J Gynecol Obstet 1996 Nov;55(2):141-145.
  18. Microvascular function in pre-eclampsia is influenced by insulin resistance and an imbalance of angiogenic mediators. Physiol Rep 2017 Apr;5(8):e13185.
  19. Insulin resistance and c-reactive protein in preeclampsia. Bosn J Basic Med Sci 2009 Aug;9(3):235-238.
  20. Ante-partum and post-partum markers of metabolic syndrome in pre-eclampsia. J Hum Hypertens 2011 Jan;25(1):11-17.
  21. Evaluation of maternal serum levels of cell adhesion molecules and endothelial inflammatory markers in normal pregnancy, gestational hypertension and pre-eclampsia. Int J Reprod Contracept Obstet Gynecol 2017 Jun;6(6):2231-2237.
  22. Maternal glucose concentration influences fetal growth, gestation and pregnancy complications. Am J Epidemiol 2001 Sep;154(6):514-520.
  23. Severe maternal insulin resistance in pregnancy: an independent predictor of fetal macrosomia. J Med Trop 2016 Oct;18(2):73-78.
  24. Insulin resistance and its potential role in pregnancy induced hypertension. J Clin Endocrinol Metab 2003 Jun;88(6):2393-2398.
  25. Physical activity before and during pregnancy and risk of gestational diabetes mellitus: a meta-analysis. Diabetes Care 2011 Jan;34(1):223-229.
  26. The effect of regular exercise on insulin sensitivity in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab J 2016 Aug;40(4):253-271.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.